IDEX Health & Science Technologies — Other segment expenses decreased by 13.8% to -$61.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.5%, from -$52.90M to -$61.10M. Over 3 years (FY 2022 to FY 2025), Health & Science Technologies — Other segment expenses shows a downward trend with a 4.0% CAGR.
Rising expenses may indicate increased investment in R&D or sales infrastructure, whereas declining expenses could signal cost-cutting or reduced operational activity.
Captures operating expenses specific to the Health and Science Technologies segment that are not classified as cost of s...
Similar to segment-level SG&A or operating expense allocations in multi-segment industrial firms.
iex_segment_health_science_technologies_other_segment_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$47.13M | -$47.13M | -$47.13M | -$47.13M | -$43.45M | -$43.45M | -$43.45M | -$43.45M | -$44.40M | -$42.00M | -$44.30M | -$51.10M | -$52.90M | -$53.30M | -$52.30M | -$53.70M | -$61.10M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.8% | +0.0% | +0.0% | +0.0% | -2.2% | +5.4% | -5.5% | -15.3% | -3.5% | -0.8% | +1.9% | -2.7% | -13.8% |
| YoY Change | — | — | — | — | +7.8% | +7.8% | +7.8% | +7.8% | -2.2% | +3.3% | -2.0% | -17.6% | -19.1% | -26.9% | -18.1% | -5.1% | -15.5% |